Opendata, web and dolomites
  1. home
  2. trasparenza
  3. open h2020
  4. medimprove

MEDimprove

A novel online service to support self-care and responsible self-medication

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0
 Outcomes and results

 MEDimprove project word cloud

Explore the words cloud of the MEDimprove project. It provides you a very rough idea of what is the project "MEDimprove" about.

responsible    started    patients    treat    medicines    otc    integrates    created    buy    convenient    minor    innovative    revenues    suggests    serfarma    euros    million    annual    software    global    professional    quality    confidential    personalized    15    cagr    patient    8    worldwide    medimprove    march    stores    medicine    medicate    2014    platform    self    provider    advertising    algorithm    supports    online    safe    integrating    variables    health    fees    dermocosmetics    life    treatment    healthcare    morbidity    invested    clinical    decision    founded    services    companies    minimize    despite    web    people    free    possibility    gives    counter    shopping    counselling    2016    150    medication    sale    environment    funds    risks    care    see    pharmaceutical    usa    easily    mortality    nearly    sales    provides    pharmacies    context    market   

Project "MEDimprove" data sheet

The following table provides information about the project.

Coordinator		 SERFARMA LDA 

Organization address
address: RUA INSTITUTO PEDRO NUNES ED C RUA PEDRO NUNES
city: COIMBRA
postcode: 3030 199
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.
 Coordinator Country Portugal [PT]
 Project website http://www.serfarma.pt
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.3.1.4. (Active ageing and self-management of health)
2. H2020-EU.2.1.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Information and Communication Technologies (ICT))
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.3.1.6. (Health care provision and integrated care)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2016
 Duration (year-month-day) from 2016-11-01   to  2017-04-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SERFARMA LDA PT (COIMBRA) coordinator 50˙000.00

Map

 Project objective

People often use over-the-counter (OTC) medicines to treat minor health problems and see these medicines as safe. Yet, like any other, OTC medicines present risks and can cause significant morbidity and mortality. To minimize these problems, the decision to self-medicate must take into account all patient's characteristics and relevant medicine information. Despite the risks, self-medication is an increasing practice worldwide and OTC medicines are easily available in stores and for online sale, without counselling from a healthcare provider, in EU and USA. In this global context, we created MEDimprove, a web platform for patients that supports responsible self-care and self-medication. The software is a clinical decision support system based on a complex algorithm that integrates all relevant patient and medicine variables and suggests the adequate safe treatment for each patient. It provides health information and personalized health counselling in a convenient, user-friendly and confidential environment. By integrating with online medicine stores, MEDimprove also gives the possibility to buy OTC medicines and other health products. For these stores, MEDimprove will increase sales by providing users with a professional and personalized counselling. Patients have free access to MEDimprove. Revenues come from: sales fees from pharmacies/medicine stores and advertising from pharmaceutical companies. We expect revenues of nearly 1.9 million euros in 3 years in a growing market of online OTC and dermocosmetics sales (which represent 15% of all online shopping and annual CAGR of the EU Market above 8%). We founded serFarma in 2014, providing innovative pharmaceutical services aiming to increase patients’ quality of life by using technology to promote the adequate use of medicines. We have invested over 150.000€ of own funds, and have started having revenues in March 2016.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "MEDIMPROVE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "MEDIMPROVE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.1.4.;H2020-EU.2.1.1.;H2020-EU.2.3.1.;H2020-EU.3.1.6.)

CLINICOVERY (2018)

CLINICOVERY, a versatile, high quality, environmental-friendly, easy to use e-Clinical solution for clinical research

Read More  

ImmuneHunter (2017)

Bioinformatics platform for profiling of health: allowing early and accurate detection of multiple diseases simultaneously

Read More  

SensUS (2018)

SensUS: A non-invasive and quantitative ultrasound (QUS) device for an objective monitoring of the childbirth labour process.

Read More